TGFB1 and neoplasm: Patients classified as high-risk showed enrichment in various processes and pathways associated with the progress and metastasis of tumor, including focal adhesion, TGF-β signaling pathway, Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway, and cell adhesion molecules (CAMs).